Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

ARX vs GOCO: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ARX Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 10–0 Matrix Metrics)

ARX Overall Winner 6-Pillar Tally: ARX 6 – 0 GOCO Matrix Metrics: ARX 10 – 0 GOCO

As of Nov 17, 2026, Accelerant Holdings (ARX) is the stronger overall head-to-head candidate over GoHealth, Inc. (GOCO) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ARX carries a Unified Composite Score of 48.3/100 (HOLD) at $19.88 (21.3x Forward P/E, 3.7% operating margin), whereas GOCO carries 42.9/100 (HOLD) at $0.30 (N/M Forward P/E, -292.0% operating margin).

  • Technical & Structure Timing Caution: ARX trades in a Markup technical trend (CONSOLIDATION options phase, RSI 69.8); meanwhile GOCO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 23.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ARX vs GOCO
ARX NYSE Head-to-Head Winner
Accelerant Holdings
Insurance Agents, Brokers & Service
$19.88
+0.05% 1D
Market Cap $4.3B
TTM Revenue $2.79B
Forward P/E 21.3x
Beta / 30D Vol -0.19β · 2% Vol
Unified Composite Score
48.3 / 100 HOLD
Tech 34.0 Fund 53.0 Flow 76.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (1.7% over 20 days), RSI 70
RSI-14: 69.8 · SMA20: $19.84 · SMA50: $19.80
GOCO NASDAQ
GoHealth, Inc. Class A Common Stock
Insurance Agents, Brokers & Service
$0.30
+5.14% 1D
Market Cap $8.5M
TTM Revenue $153M
Forward P/E N/M
Beta / 30D Vol 2.15β · 201% Vol
Unified Composite Score
42.9 / 100 HOLD
Tech 40.0 Fund 46.0 Flow 50.0 Mom 48.9
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -32.2%), weak momentum, RSI 24
RSI-14: 23.9 · SMA20: $0.59 · SMA50: $0.88

6-Pillar Scorecard Institutional Category Breakdown (ARX 6 – 0 GOCO)

Columns: Metric · ARX · GOCO
1. Valuation Multiples ARX
Forward P/E 21.3x N/M
Trailing P/E 27.6x N/M
PEG Ratio N/M N/M
EV / Revenue N/M 0.1x
2. Growth & Scale ARX
Revenue Growth (YoY) +6.1% -94.6%
Earnings Growth (YoY) +800.0% +424.1%
TTM Revenue (USD) $2.79B $153M
Market Cap $4.3B $8.5M
3. Profitability & Quality ARX
Gross Margin 62.8% 57.3%
Operating Margin 3.7% -292.0%
Net Profit Margin 5.6% -189.7%
Return on Equity (ROE) 9.2% -289.9%
4. Balance Sheet & Cash Flow ARX
Cash Generation (TTM) $634M -$148M EBITDA
Cash Flow Margin 22.7% -96.9% EBITDA Mgn
Net Cash / Leverage $5.13B Net Cash $0.13 Book/Sh · -289.9% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning ARX
Options Structure Phase CONSOLIDATION UNCLASSIFIED
Current IV / %ile 15.7% (3rd %ile) N/A (N/A)
Put/Call OI Skew 0.01x (Call-Skewed) N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Markdown
6. R&D & Supply-Chain Moat ARX
OpEx & R&D Intensity 59.1% of Rev ($1.65B) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Insurance Brokers Operator Insurance Brokers Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ARX (10) vs GOCO (0)
Institutional Metric ARX GOCO Criterion Row Edge
Market Capitalization
Scale
$4.3B $8.5M Larger Scale ARX
Trailing P/E Ratio
Valuation
27.6x N/M Lower Multiple ARX
Forward P/E Ratio
Valuation
21.3x N/M Lower Multiple ARX
Revenue Growth (YoY)
Growth
+6.1% -94.6% Higher Growth ARX
Operating Margin (TTM)
Profitability
3.7% -292.0% Higher Margin ARX
Net Profit Margin
Profitability
5.6% -189.7% Higher Margin ARX
Return on Equity (ROE)
Capital Efficiency
9.2% -289.9% Higher ROE ARX
52-Week Range Position
Momentum
100% ($9–$20) 0% ($0–$7) Stronger Trend ARX
Beta / 30D Volatility
Risk Regime
-0.19β · 2% Vol 2.15β · 201% Vol Lower Realized Risk ARX
Unified Institutional Score
Composite Signal
48.3 / 100 (HOLD) 42.9 / 100 (HOLD) Higher Composite ARX
Trailing 12M Revenue (USD)
Operating Scale
$2.79B $153M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
62.8% 57.3% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 0.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$634M ($5.13B Net Cash) -$148M EBITDA ($0.13 Book/Sh · -289.9% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ARX +53.67 pp
ARX: -11.02% · GOCO: -64.69%
3M Horizon ARX +98.32 pp
ARX: +16.8% · GOCO: -81.52%
6M Horizon ARX +73.2 pp
ARX: -17.36% · GOCO: -90.56%
1Y Horizon ARX +83.84 pp
ARX: -4.13% · GOCO: -87.97%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ARX vs GOCO. Trailing 12-month operating profitability (ARX 3.7% vs GOCO -292.0%) and valuation multiples (ARX 21.3x vs GOCO N/M Forward P/E) are benchmarked directly in Pillar 4 below.

ARX ADR TTM Benchmark FX-Normalized USD
TTM Revenue$2.79B
Gross Margin62.8%
Op. Margin3.7%
ROE / Fwd P/E9.2% · 21.3x
GOCO ADR TTM Benchmark FX-Normalized USD
TTM Revenue$153M
Gross Margin57.3%
Op. Margin-292.0%
ROE / Fwd P/E-289.9% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ARX CONSOLIDATION
51d in phase · OBV NEUTRAL
Current IV 15.7%
IV Percentile 3rd %ile
Put/Call OI Skew 0.01x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact ARX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
GOCO UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact GOCO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ARX Moat Profile Cyclical / Execution-Driven Positioning
Insurance Brokers Operator
Competes within the Insurance Brokers value chain with $4.3B market capitalization and 3.7% operating margin.
OpEx & R&D Reinvestment 59.1% of Rev ($1.65B)
90D Engineering Disclosures 0 Published
GOCO Moat Profile Cyclical / Execution-Driven Positioning
Insurance Brokers Operator
Competes within the Insurance Brokers value chain with $8.5M market capitalization and -292.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ ARX vs GOCO Key Questions & Quantitative Answers

As of Nov 17, 2026, Accelerant Holdings (ARX) is the stronger overall head-to-head candidate over GoHealth, Inc. (GOCO) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ARX carries a Unified Composite Score of 48.3/100 (HOLD) at $19.88 (21.3x Forward P/E, 3.7% operating margin), whereas GOCO carries 42.9/100 (HOLD) at $0.30 (N/M Forward P/E, -292.0% operating margin). Technical & Structure Timing Caution: ARX trades in a Markup technical trend (CONSOLIDATION options phase, RSI 69.8); meanwhile GOCO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 23.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ARX leads the Growth & Scale pillar: ARX posts +6.1% YoY revenue growth and +800.0% YoY earnings growth on $2.79B TTM revenue (62.8% gross margin, 3.7% operating margin), compared with GOCO at -94.6% YoY revenue growth and +424.1% YoY earnings growth on $153M TTM revenue (57.3% gross margin, -292.0% operating margin). On trailing 12-month operating scale, ARX generates $2.79B in USD-normalized revenue versus $153M for GOCO. In operating R&D and SG&A reinvestment, ARX deploys 59.1% of Rev ($1.65B) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for GOCO.

ARX screens cheaper on headline valuation multiples. ARX trades at 21.3x Forward P/E, 27.6x Trailing P/E, N/M PEG, and N/M EV/Revenue (22.7% FCF margin), whereas GOCO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-96.9% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ARX (9.2% ROE) versus GOCO (-289.9% ROE) capital efficiency.

In options market volatility and institutional positioning, ARX carries 15.7% implied volatility (3rd %ile, Compressed (<25th %ile)), a 0.01x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.19β · 2% Vol realized risk). By comparison, GOCO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.15β · 201% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.